CYCLERION THERAPEUTICS, INC. Deferred Tax Assets, Tax Deferred Expense, Other
CYCLERION THERAPEUTICS, INC. (CYCN) had Deferred Tax Assets, Tax Deferred Expense, Other of $0 as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Notes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther · last filed 2023-03-22
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $0.00.
- 2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Other $4.00K.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Other |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-22 |
| 2021-12-31 | $4.00K 10-K · filed 2023-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |